Incyte Genomics (INCY) Misses Q2 Views
Tweet
Share
E-mailGet Alerts INCY Hot Sheet
Price: $126.01 +1.29%
EPS Growth %: -225.2%
Financial Fact:
Income (loss) before income taxes: 38.3M
Today's EPS Names:
SUNB, CULP, KFY, More
EPS Growth %: -225.2%
Financial Fact:
Income (loss) before income taxes: 38.3M
Today's EPS Names:
SUNB, CULP, KFY, More
Join SI Premium – FREE
Incyte Genomics (NASDAQ: INCY) reported Q2 EPS of ($0.41), $0.05 worse than the analyst estimate of ($0.36). Revenue for the quarter came in at $16.8 million versus the consensus estimate of $19.17 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Cooper Cos. (COO) Tops Q3 EPS by 3c, Offers Guidance
- Cognyte Software (CGNT) Tops Q2 EPS by 4c
- Signet Jewelers (SIG) Tops Q2 EPS by 47c, Misses on Revenue; Offers FY27 Guidance
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
